Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

BACKGROUND: Monovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A multisite study was established in 2 population-based surveillance sites to evaluate vaccine impact on the incidence of rota...

Descripción completa

Detalles Bibliográficos
Autores principales: Otieno, Grieven P, Bottomley, Christian, Khagayi, Sammy, Adetifa, Ifedayo, Ngama, Mwanajuma, Omore, Richard, Ogwel, Billy, Owor, Betty E, Bigogo, Godfrey, Ochieng, John B, Onyango, Clayton, Juma, Jane, Mwenda, Jason, Tabu, Collins, Tate, Jacqueline E, Addo, Yaw, Britton, Tuck, Parashar, Umesh D, Breiman, Robert F, Verani, Jennifer R, Nokes, D James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245159/
https://www.ncbi.nlm.nih.gov/pubmed/31544211
http://dx.doi.org/10.1093/cid/ciz912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245159/
https://www.ncbi.nlm.nih.gov/pubmed/31544211
http://dx.doi.org/10.1093/cid/ciz912

Ejemplares similares